The same drugs are way cheaper in Germany than in America…
“The same drugs are way cheaper in Germany than in America because, obviously, if all sickness funds negotiate with the drug companies for a single price, then the market power of the sickness funds is fully used. So therefore you would expect the prices to be lower for the drugs in Germany, and this is exactly what you see, at least for non-generic drugs.”
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
If health insurers collectively negotiate drug prices, they can leverage market power to lower costs, which explains why Germany’s prices are lower than America’s for many non‑generic medicines.
In simple terms: Collective bargaining by insurers can reduce drug prices.
Key Takeaway
Support strong price negotiations.
Themes
healthcare economics
policy
pricing
international comparison
pharmaceuticals
Mood
analytical
critical
informative
Type
policy statement
economic analysis
When to use this quote
- government health insurance negotiations
- pharmaceutical procurement
- policy reform discussions
- comparative health system analysis
- advocacy for price controls
Key Concepts
market power
collective bargaining
price regulation
drug pricing
Questions to Reflect On
- How can other countries adopt similar negotiation models?
- What barriers exist to implementing collective bargaining in the US?
A Different Perspective
Negotiation power may be limited by legal constraints or pharmaceutical lobbying.